by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

Pure Indulgence Aesthetics Warning Letter Details

Warning Letter

Pure Indulgence Aesthetics

1695 East Southlake Boulevard Suite 150 Southlake , TX 76092 United States

Issue DateApril 01, 2026

FEI Number3041017461

Violations1

CountryUnited States

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

Drug Supply Chain Security Act (DSCSA) Violations

Pure Indulgence Aesthetics FDA Warning Letter, April 1, 2026